148 related articles for article (PubMed ID: 8101691)
1. Sedation from H1 antagonists: evaluation methods and experimental results.
Passalacqua G; Scordamaglia A; Ruffoni S; Parodi MN; Canonica GW
Allergol Immunopathol (Madr); 1993; 21(2):79-83. PubMed ID: 8101691
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
4. Sedation and performance issues in the treatment of allergic conditions.
Adelsberg BR
Arch Intern Med; 1997 Mar; 157(5):494-500. PubMed ID: 9066452
[TBL] [Abstract][Full Text] [Related]
5. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
6. Non sedating antihistamines.
Katelaris CH
Aust Fam Physician; 1993 Sep; 22(9):1649-53. PubMed ID: 7902082
[TBL] [Abstract][Full Text] [Related]
7. Loratadine in the high performance aerospace environment.
Hansen GR
Aviat Space Environ Med; 1999 Sep; 70(9):919-24. PubMed ID: 10503759
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system side-effects of antihistamines in schoolchildren.
Feldman W; Shanon A; Leiken L; Ham-pong A; Peterson R
Rhinol Suppl; 1992 Sep; 13():13-9. PubMed ID: 1358139
[TBL] [Abstract][Full Text] [Related]
10. Risks of non-sedating antihistamines.
Lindquist M; Edwards IR
Lancet; 1997 May; 349(9061):1322. PubMed ID: 9142080
[No Abstract] [Full Text] [Related]
11. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
12. Cardiac actions of antihistamines.
Woosley RL
Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
14. The comparative pharmacokinetics of H1-receptor antagonists.
Simons FE; Simons KJ; Chung M; Yeh J
Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
[TBL] [Abstract][Full Text] [Related]
15. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
Mann RD; Pearce GL; Dunn N; Shakir S
BMJ; 2000 Apr; 320(7243):1184-6. PubMed ID: 10784544
[TBL] [Abstract][Full Text] [Related]
16. Safety of second generation antihistamines.
Philpot EE
Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
[TBL] [Abstract][Full Text] [Related]
17. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance.
Kay GG; Berman B; Mockoviak SH; Morris CE; Reeves D; Starbuck V; Sukenik E; Harris AG
Arch Intern Med; 1997 Nov; 157(20):2350-6. PubMed ID: 9361576
[TBL] [Abstract][Full Text] [Related]
18. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
[TBL] [Abstract][Full Text] [Related]
19. H1-receptor antagonists: safety issues.
Estelle F; Simons R
Ann Allergy Asthma Immunol; 1999 Nov; 83(5):481-8. PubMed ID: 10582735
[TBL] [Abstract][Full Text] [Related]
20. Newer antihistamines.
Med Lett Drugs Ther; 2001 Apr; 43(1103):35. PubMed ID: 11331439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
